1. Dealing with global safety issues – was the response to QT-liability of non-cardiac drugs well coordinated?;Stockbridge;Drug Saf,2013
2. Drug-induced prolongation of the QT interval;Roden;N Engl J Med,2004
3. ICH Topic S7B the Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals;International Conference on Harmonisation,2005
4. Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs;ICH,2005
5. Quantitative analysis of the disopyramide concentration-effect relationship;Whiting;Br J Clin Pharmacol,1980